CJC-1295 Without DAC + IPA x 10 Vials

CJC-1295 Without DAC + IPA x 10 Vials are supplied as a research peptide combination for laboratory investigations involving growth hormone signalling, GHRH receptor pathways, secretagogue biology, and neuroendocrine research.

This combination brings together a CJC-1295 variant without Drug Affinity Complex (DAC) and Ipamorelin (IPA). The two compounds are studied through different but complementary endocrine signalling pathways, making the combination relevant to research into growth hormone regulation and peptide-receptor interactions.

Research Use Only. Not for human consumption, self-administration, diagnosis, treatment, or prevention of disease.

CJC-1295 Without DAC + IPA in Growth Hormone Research

Growth hormone regulation involves several interconnected signalling systems.

The CJC-1295 No DAC component is associated with research into growth hormone-releasing hormone (GHRH) pathways, while Ipamorelin belongs to the growth hormone secretagogue family and is studied in relation to GHS-R1a.

Together, these pathways provide a useful model for investigating:

• Growth hormone signalling
• GHRH receptor biology
• GHS-R1a receptor activity
• Pituitary signalling
• Neuroendocrine communication
• Peptide-receptor interactions
• Endocrine regulation

What Is CJC-1295 Without DAC?

CJC-1295 is a synthetic peptide related to growth hormone-releasing hormone research.

The term Without DAC distinguishes this form from the CJC-1295 variant containing the Drug Affinity Complex. The absence of DAC is an important structural distinction because the two forms have different pharmacological characteristics.

In research settings, the No DAC variant is generally examined in relation to GHRH receptor signalling and growth hormone pathways.

What Is Ipamorelin?

Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue.

Its research profile is associated with the growth hormone secretagogue receptor 1a (GHS-R1a). This receptor is also closely linked with ghrelin-related signalling.

Laboratory investigations can therefore use Ipamorelin as a model for studying:

• Secretagogue receptor activity
• Pituitary signalling
• Growth hormone pathways
• GPCR biology
• Neuroendocrine communication

How the Two Research Pathways Differ

The two components are distinct research molecules with different primary receptor systems.

Component	Primary research pathway	General classification
CJC-1295 No DAC	GHRH receptor	GHRH-related peptide
Ipamorelin	GHS-R1a	Growth hormone secretagogue

This distinction is important because the compounds do not simply represent two versions of the same molecule.

Instead, they provide researchers with separate models for investigating different regulatory inputs within the growth hormone axis.

GHRH Receptor Research

Growth hormone-releasing hormone is an important hypothalamic regulator of pituitary growth hormone secretion.

GHRH-related research focuses on the interaction between this signalling molecule and its receptor on pituitary somatotroph cells.

Researchers may investigate:

• GHRH receptor activation
• Intracellular signalling
• Pituitary responses
• Hormonal feedback
• Growth hormone regulation
• Receptor pharmacology

The No DAC variant provides a research model associated with this pathway.

GHS-R1a and Secretagogue Research

The second component is studied primarily through GHS-R1a.

GHS-R1a is a G-protein-coupled receptor associated with ghrelin signalling and growth hormone secretagogue activity.

Research into this receptor can examine:

• GPCR activation
• Calcium signalling
• Intracellular pathways
• Pituitary cell responses
• Hormonal signalling
• Receptor-ligand interactions

This creates a useful contrast with GHRH receptor research.

CJC-1295 No DAC and Growth Hormone Signalling

Growth hormone-producing somatotroph cells respond to multiple regulatory inputs.

GHRH provides stimulatory signalling, while somatostatin acts as an important inhibitory regulator. Secretagogue pathways represent another signalling mechanism involved in experimental endocrine research.

Understanding these separate inputs helps researchers examine the complexity of pituitary hormone regulation.

Combined Peptide Research

Combination research can be useful when scientists want to investigate how separate receptor systems interact.

A GHRH-related peptide and a secretagogue can provide models for studying different upstream mechanisms associated with the same endocrine pathway.

Potential research areas include:

Receptor Biology

Scientists can compare signalling produced through the GHRH receptor and GHS-R1a.

Pituitary Research

Experimental models can investigate how different extracellular signals influence somatotroph-related pathways.

Neuroendocrinology

The combination is relevant to studies of communication between hypothalamic and pituitary systems.

Endocrine Signalling

Researchers can examine how multiple regulatory inputs interact within the growth hormone axis.

CJC-1295 No DAC vs CJC-1295 DAC

The terms No DAC and DAC refer to structurally different versions of CJC-1295.

Feature	No DAC	DAC
Drug Affinity Complex	Absent	Present
Research classification	GHRH-related peptide	Modified GHRH-related analogue
Research focus	GHRH receptor signalling	Extended pharmacological characteristics
Molecular profile	Distinct from DAC version	Distinct from No DAC version

These differences should be considered when comparing experimental data involving the two forms.

CJC-1295 No DAC vs Ipamorelin

These compounds should also be distinguished according to their primary signalling pathways.

Feature	CJC-1295 No DAC	Ipamorelin
General class	GHRH-related peptide	Growth hormone secretagogue
Primary research target	GHRH receptor	GHS-R1a
Research field	Growth hormone regulation	Secretagogue signalling
Receptor family	GHRH receptor pathway	GPCR

This makes them complementary research subjects rather than interchangeable materials.

Growth Hormone and IGF Research

Growth hormone signalling is connected with the broader insulin-like growth factor (IGF) system.

Research into the somatotropic axis may examine relationships involving:

• Growth hormone
• IGF-1
• GHRH
• Somatostatin
• GHS-R1a
• IGF receptors
• Endocrine feedback

These pathways are interconnected, but each molecule has a distinct biological role.

Neuroendocrine Research

Neuroendocrinology examines communication between neural and endocrine systems.

The hypothalamus and pituitary gland form an important part of this network. Peptide signalling provides researchers with experimental models for studying how extracellular signals regulate endocrine activity.

Research can explore:

• Hypothalamic signalling
• Pituitary receptor activity
• Hormone feedback
• Neuroendocrine communication
• Cellular signal transduction

Research Applications

This peptide combination may be relevant to laboratory research involving:

• Growth hormone pathways
• GHRH receptor research
• GHS-R1a receptor biology
• Pituitary signalling
• Neuroendocrinology
• GPCR research
• Peptide receptor pharmacology
• Endocrine feedback
• Growth-factor signalling

Researchers should select experimental models according to their specific scientific objectives and validated laboratory protocols.

CJC-1295 Without DAC + IPA x 10 Vials Format

The listed product format contains 10 individual research vials.

The exact labelled quantity per vial should be confirmed using the current product specification, packaging, and batch documentation.

Researchers should not assume a specific total peptide quantity without verifying the strength stated for each vial.

Product Quality and Documentation

Quality control is an important consideration when evaluating research peptides.

Researchers should review available documentation covering:

• Peptide identity
• Purity
• Batch or lot number
• Certificate of Analysis
• Analytical testing
• Manufacturing specifications
• Packaging
• Storage requirements

Clear documentation supports reproducibility and helps laboratories evaluate research-material suitability.

Storage Considerations

Storage requirements should follow the manufacturer’s current documentation.

Researchers should consider:

• Temperature
• Moisture
• Light exposure
• Packaging integrity
• Stability information
• Handling requirements

Product-specific instructions should always take priority because storage requirements can differ between formulations.

Research-Only Information

This material is presented exclusively for scientific and laboratory research.

It should not be presented as a medicine, hormone therapy, bodybuilding product, or nutritional supplement. Experimental peptide research should not automatically be interpreted as evidence of safety or effectiveness in humans.

Researchers should follow appropriate laboratory procedures, institutional policies, and applicable regulations.

Frequently Asked Questions

What is CJC-1295 Without DAC?

It is a CJC-1295 variant studied in relation to GHRH receptor signalling and growth hormone research, without the Drug Affinity Complex associated with the DAC form.

What does IPA mean?

In this product context, IPA refers to Ipamorelin, a synthetic growth hormone secretagogue studied in relation to GHS-R1a.

What receptors are involved?

The two components are associated with different pathways: the CJC-1295 No DAC component with the GHRH receptor and Ipamorelin with GHS-R1a.

Is CJC-1295 No DAC the same as CJC-1295 DAC?

No. They are structurally different variants with different research and pharmacological characteristics.

Is this the same as growth hormone?

No. These are synthetic research peptides studied in relation to signalling pathways involved in growth hormone regulation. They are not growth hormone itself.

How many vials are included?

The listed format contains 10 individual vials. The precise amount per vial should be confirmed from the current product specification.

Is this product intended for human use?

No. It is presented for laboratory research only and is not intended for human consumption or self-administration.

Summary

CJC-1295 Without DAC + IPA x 10 Vials provide a research format combining a GHRH-related peptide with a growth hormone secretagogue.

The two components are studied through distinct receptor pathways, providing researchers with a model for investigating GHRH signalling, GHS-R1a biology, pituitary regulation, growth hormone pathways, and neuroendocrine communication.

As with other research peptides, appropriate documentation, laboratory controls, and applicable research regulations should be followed.

 

ipamorelin​,
cjc 1295​,
cjc-1295​,
cjc 1295 ipamorelin​,
cjc1295​,
ipamorelin peptide​,
cjc-1295 ipamorelin,​
cjc peptide​,
ipamorelin dosage​.